Submitting a reimbursement application in Japan involves these steps: obtaining regulatory approval from PMDA, preparing evidence of clinical efficacy, safety, & cost-effectiveness, submitting the application to MHLW, undergoing review by Chuikyo for classification & pricing, & final inclusion in the National Health Insurance (NHI) reimbursement list. Thorough documentation is critical throughout the process.
